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Cultivation of aorta-gonad-mesonephros–derived hematopoietic stem cells in the
fetal liver microenvironment ampliﬁes long-term repopulating activity and
enhances engraftment to the bone marrow
Masaki Takeuchi, Takashi Sekiguchi, Takahiko Hara, Taisei Kinoshita, and Atsushi Miyajima
During mammalian development, deﬁni-
tivehematopoieticstemcells(HSCs)arise
in the aorta-gonad-mesonephros (AGM)
region and colonize the fetal liver (FL)
before hematopoiesis occurs in the bone
marrow. The FLis a unique hematopoietic
organwherebothHSCsandmatureblood
cells are actively generated along with
functional maturation of hepatic cells as a
metabolic organ. To characterize HSCs
and FL microenvironments during devel-
opment, this study establishes a cocul-
ture system composed of AGM-origi-
nated HSCs and FL nonhematopoietic
cells. The results demonstrate that FL
cells support signiﬁcant expansion of lin-
eage-committed hematopoietic cells as
wellasimmatureprogenitors.Moreimpor-
tant, long-term repopulating activity was
ampliﬁed from AGM-originated HSCs in
this coculture system. Engraftment of
HSCs to the bone marrow was strongly
enhanced by coculture. In addition, AGM
HSCs produced signiﬁcantly more hema-
topoietic cells than E14.5 and E18.5 FL
HSCs in vitro. These results suggest that
the FL microenvironment not only stimu-
lates expansion of the hematopoietic sys-
tem, but also possibly modiﬁes the char-
acteristics of AGM HSCs. Thus, this
coculture system recapitulates the devel-
opmental process of HSCs and the FL
microenvironment and provides a novel
meanstostudythedevelopmentofhema-
topoiesis. (Blood. 2002;99:1190-1196)
© 2002 by TheAmerican Society of Hematology
Introduction
Development of the hematopoietic system is a complex process
that takes place in several distinct hematopoietic microenviron-
ments.1-3 The initial hematopoietic activity, known as primitive
hematopoiesis, appears in the blood island of the yolk sac (YS) at
embryonicday7.5(E7.5)inmice.Adult-typedeﬁnitivehematopoi-
esis begins in the aorta-gonad-mesonephros (AGM) region at
E10.54,5 and thereafter shifts to the fetal liver (FL) at E12.5, where
massive production of various hematopoietic cells occurs. Then,
near birth, hematopoiesis shifts to the bone marrow and spleen.
Therefore, the FL is a main hematopoietic organ during the
embryonic period. The transition of hematopoietic sites accompa-
nies changes in the characteristics of hematopoietic activity.3
Primitive hematopoiesis in theYS is characterized by production of
nucleated erythrocytes with fetal hemoglobin and by the absence of
lymphoid and myeloid cells except for macrophages.6-8 However,
YS cells are unable to reconstitute all types of hematopoietic cells
in lethally irradiated adult mice for more than several months
(long-term repopulating hematopoietic stem cells [LTR HSCs]),
which is the most important characteristic of deﬁnitive HSCs.9
HSCs with such activity ﬁrst appear in the AGM region at E10.5
and thereafter colonize the FL and bone marrow. Therefore, the
AGM region has been considered the origin of deﬁnitive HSCs.
Interestingly,however,YS-derivedhematopoieticcellswereshown
to reconstitute the entire hematopoietic system when grafted into
the liver of busulfan-treated newborn recipients.10-12These ﬁndings
suggest that YS-derived hematopoietic cells acquire the HSC
activity by the interaction with a speciﬁc hematopoietic microenvi-
ronment in the liver of newborn mice in which hematopoiesis is
sustained. In addition, the CD341/c-Kit1 rather than the CD342/
c-Kit1 population in YS was able to reconstitute hematopoiesis in
this transplantation system,11 distinguishing YS HSCs from bone
marrow HSCs.13 Thus, the characteristics of HSCs are different
among the hematopoietic organs, and the microenvironment cre-
ated by each tissue appears to affect the stem cell activity and
expression of cell-surface antigens in HSCs.
Although HSCs in bone marrow replicate at a constant rate to
maintain hematopoiesis throughout life,14,15 HSCs in embryonic
organs are believed to proliferate actively during development.3
Accumulating evidence suggests that deﬁnitive HSCs differentiate
from their precursors, hemangioblasts, in the AGM at about E10.5
to E11.516 and colonize to the FL, where the most dramatic
expansion of HSCs occurs from E11.5 through E14.5.17,18 Thereaf-
ter, the expansion of HSCs declines along with development18 and
is essentially terminated around birth. Thus, the proliferative
potential of HSCs can be different from stage to stage during
development. The FL provides a distinct hematopoietic microenvi-
ronment that enables signiﬁcant proliferation of HSCs, especially
in the early phase of its development. On the other hand, fetal
hepatic cells undergo their own maturation process to become a
center of metabolism, while they function as a major hematopoietic
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various liver-speciﬁc genes is also regulated by extracellular
signals such as hormones, cytokines, and extracellular matrices.
Thus, in the FL, the 2 different cellular systems coexist and
undergo their own developmental processes.
To clarify the mechanism of hematopoietic development in the
AGM region, we previously developed a primary culture system of
AGM-derived cells and demonstrated that oncostatin M (OSM), an
interleukin-6 (IL-6) family cytokine, stimulates development of
multilineage progenitors from the AGM cells in vitro.21 We also
established a primary culture system of nonhematopoietic cells
from E14.5 liver and found that OSM in the presence of dexameth-
asone (Dex), a synthetic glucocorticoid, induces maturation of fetal
hepatocytes, as evidenced by morphologic changes that closely
resemble differentiated hepatocytes, expression of various liver
enzymes, accumulation of intracellular glycogen, lipid synthesis,
and clearance of ammonia.22,23 Moreover, those FL cells also
supported hematopoiesis in vitro and interestingly, such activity
declined along with liver development.24 OSM is expressed in
CD451 hematopoietic cells in FL, whereas the OSM receptor is
expressed predominantly in hepatocytes, suggesting that OSM is a
paracrine factor in FL.22
Because HSCs generated inAGM are expected to proliferate in
FL, we describe here a coculture system in which HSCs derived
from E11.5AGM (AGM HSCs) are cultivated in the microenviron-
ment created by FL nonhematopoietic cells. AGM HSCs prolifer-
atedmoreefﬁcientlythanFLHSCsintheinvitroFLmicroenviron-
ment, and, most important, LTR-HSC activity was signiﬁcantly
increased in this system. These culture systems enabled us to
analyze the characteristics of HSCs and microenvironments in
AGM and FL separately and provided novel in vitro models to
study the development of hematopoiesis and hepatocytes.
Materials and methods
Mice
C57BL/6 mice were purchased from Nihon SLC (Hamamatsu, Japan). To
distinguish the donor cells from host cells after transplantation and
coculture, we isolated donor cells from transgenic mice expressing the
green ﬂuorescent protein25 (GFP mice were from Dr M. Okabe, Osaka
University). GFP1 male mice were mated with GFP2 female mice;
therefore, the donor GFP1 cells were derived exclusively from the GFP1
embryos but not from contamination of maternal blood cells.The GFPmice
were maintained and mated in the institutional animal facility according to
our institutional guideline. The time at midday was considered as E0.5 for
plugged mice.
Antibodies and cytokines
Monoclonal antibodies used for cell-surface analysis, phycoerythrin-
conjugated anti–Mac-1 (M1/70), anti–Gr-1 (RB6-8C5), anti–Thy-1.2 (30-
H12), anti-B220 (RA3-6B2), anti–Ter-119 (Ter-119), anti–c-Kit (3C1),
biotinylated anti-CD34 (RAM34), and Sca1 (E13-161.7) were obtained
from Pharmingen (San Diego, CA). The biotinylated antibody was visual-
ized by allophycocyanin (APC)-conjugated streptavidin (Molecular Probe,
Eugene, OR). Murine IL-3 was produced in silkworms and puriﬁed as
described previously.26 IL-6 and erythropoietin (EPO) were provided by
Ajinomoto (Tokyo, Japan) and Kirin Brewery (Tokyo, Japan), respectively.
AGM culture
Primary culture of theAGM cells was performed as described previously.21
In brief, theAGM region was excised from E11.5 GFP1 C57BL/6 embryos
and dissociated into a single-cell suspension by trypsin digestion. The cells
were cultured in Dulbecco modiﬁed Eagle medium (DMEM) supplemented
with 15% fetal calf serum (FCS) in the presence of various cytokines: 100
ng/mL stem cell factor (SCF), 1 ng/mL basic ﬁbroblast growth factor
(bFGF; Gibco-BRL, Carlsbad, CA), 10 ng/mL murine leukemia inhibitory
factor (mLIF), and 10 ng/mL mOSM. After 10 days of incubation,
nonadherent hematopoietic cells spontaneously generated in cultures were
harvested and analyzed for expression of cell-surface markers and
progenitor activities.
AGM/FL coculture
FL cells were isolated from the E14.5 embryos as described previously22
and used as hematopoietic stromal cells.24 The cells were suspended in
DMEM supplemented with 10% FCS, Insulin-Ferritin-X solution (Gibco-
BRL), and 1 3 1027 M Dex, and inoculated onto 0.1% gelatin-coated
plastic dishes. A few hours later, the cells were washed extensively with
phosphate-buffered saline to eliminate hematopoietic cells. Two days later,
sources of hematopoietic cells were overlaid onto FL cells and cultured in
DMEM supplemented with 15% FCS in the presence of various cytokines,
100 ng/mL SCF, 10 ng/mL mOSM, Insulin-Ferritin-X solution, and
1 3 1027 M Dex.After incubation for 10 days, the cells were harvested for
further analysis.
Flow cytometry
Cells generated in vitro or from the recipient mice were ﬁltered through a
nylon mesh to remove cell aggregates and debris. After staining with a
monoclonal antibody according to the manufacturer’s protocol, cells were
analyzed by ﬂuorescence-activated cell sorting (FACS) with the FACS-
Calibur system or sorted by the FACS-Vantage system (Becton Dickinson,
San Jose, CA) for further analysis
Culture colony-forming unit assay
For analysis of the progenitor activity of cells generated during cultures,
donor-derived GFP1 hematopoietic cells were sorted by FACS Vantage
(Becton Dickinson) and applied for assays. Two thousand hematopoietic
cells were suspended in 1 mLa-minimal essential medium containing 0.8%
methylcellulose, 30% FCS, 1% deionized bovine serum albumin, 100 mM
2-mercaptoethanol, 10 ng/mLIL-3, 100 ng/mLIL-6, 2 U/mLEPO, and 100
ng/mL SCF and plated onto plastic dishes (35 mm in diameter). Colony
types were judged from the morphology under microscopic observation on
day 14 after plating.27
In vivo repopulating assay
Adult mice (C57BL/6 males, 9-12 weeks old) were exposed to a single dose
of 10 Gy from a 137Cs source.At this dose, all irradiated mice died within 2
weeks. Test cells were ﬁltered through a nylon mesh of 70 mm (Cell
Strainer; Becton Dickinson, San Jose, CA) and injected intravenously into
the tail vein. Normal bone marrow cells (2 3 105) were coinjected with the
test cells for radioprotection. Under this experimental condition, 10% to
20% of mice undergoing transplantation died within 2 weeks. Several
months later, peripheral blood cells were collected from the tail vein and
analyzed by ﬂow cytometry. To examine the tissue distribution of donor
cells, we killed the recipient mice; collected blood cells from the bone
marrow, thymus, spleen, and peripheral blood; and analyzed them by
ﬂow cytometry.
Results
Establishment of a coculture system composed of AGM HSCs
and FL nonhematopoietic cells
Deﬁnitive HSCs generated in AGM immediately colonize to the
FL, in which they replicate themselves and generate numerous
mature blood cells.To clarify the interaction between HSCs and the
FL microenvironment, we developed the coculture system (Figure
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inoculated in subconﬂuent cultures of nonhematopoietic FL cells
from nontransgenic mice and incubated in the presence of cyto-
kines and hormones. After 10 days of incubation, numerous cells
ﬂoating above the hepatic stromal layer were generated. Flow
cytometric analysis of hematopoietic cell-surface markers as well
as microscopic observation indicated that these ﬂoating cells were
hematopoietic cells (data not shown).To compare the differences in
the hematopoietic microenvironments between AGM and FL, we
counted the number of GFP1 ﬂoating cells by FACS and found that
theAGM/FLcoculture produced more hematopoietic cells than the
AGM culture (Figure 2). It is therefore likely that the FL
microenvironment is more suitable than that of AGM for AGM
HSCs to produce hematopoietic cells.
We next examined the factors required for hematopoiesis in the
2 culture systems. SCF was essential for hematopoiesis in both
AGM culture andAGM/FL coculture (data not shown). In contrast
toAGM culture, which requires OSM for hematopoiesis, OSM was
not absolutely required for the production of hematopoietic cells in
AGM/FL coculture (Figure 2, lane b). In agreement with our
previous observation24 that hematopoiesis from FL-derived HSCs
in the FL microenvironment in vitro was inhibited by OSM and
Dex, the number of cells produced in AGM/FL coculture was
signiﬁcantly reduced in the presence of OSM and Dex (Figure 2,
lanes b-d).
Characteristics of AGM HSCs and FL HSCs
Because LTR HSCs in AGM were reported to express CD34 and
c-Kit,28 we fractionated AGM-derived cells into 2 populations: the
CD341/c-Kit1 cells and the remainder (ie, CD341/c-Kit2, CD342/
c-Kit1, and CD342/c-Kit2 cells), and examined their potential to
generate hematopoietic cells in the AGM/FL coculture system
(Figure 3). We found that hematopoietic cells were produced only
from the CD341/c-Kit1 population in AGM, but not from the
remaining cell populations (data not shown). Furthermore, the
efﬁciency of expansion was higher in the culture with CD341/
c-Kit1 cells than in the culture with the whole AGM cells. These
ﬁndings indicate that the CD341/c-Kit1 cells in AGM produce
hematopoietic cells, and the remaining cells neither give rise to
hematopoietic cells nor enhance hematopoiesis in the
coculture system.
Because LTR HSCs in FL are present in the lineage2/CD341/
c-Kit1 population,28 production of hematopoietic cells from the
CD341/c-Kit1 cells derived from E14.5 and E18.5 FL in the FL
microenvironment was compared with that from E11.5 AGM. The
AGM-derived CD341/c-Kit1 cells produced the highest number of
hematopoietic cells among the 3 sources of HSCs (Figure 3).
Because the hematopoietic activity of the E18.5 FL CD341/c-Kit1
cells was considerably less than that of E14.5 FL, it is likely that the
Figure 3. Expansion of AGM- or FL-derived CD341/c-Kit1 cells in the FL
microenvironment. CD341/c-Kit1 cells were sorted from E11.5 AGM, E14.5 FL, or
E18.5 FL and cultured in the E14.5 FL microenvironment. The number of GFP1
ﬂoating cells generated over the stromal layer was counted by FACS on day 10.
Under these culture conditions, 40% to 80% of ﬂoating cells were GFP1. Results are
shown as fold expansion relative to the number of input CD341/c-Kit1 cells in each
culture condition. (Lane a) Whole AGM cells from 3 embryos containing 1.8 3 104
CD341/c-Kit1 cells were cultured in the microenvironment created by the AGM cells.
(Lanes b-d) Whole AGM cells (1 3 105) containing 2 3 103 CD341/c-Kit1 cells were
cocultured in the FL microenvironment in the presence of various factors, as
indicated. (Lanes e-m) CD341/c-Kit1 cells (2 3 103) from different sources were
cultured in the FL microenvironment under various culture conditions. Data shown
are the mean 6 SD of at least triplicate experiments.
Figure 1. Primary culture systems used in this study. (A) AGM culture. AGM
culture was developed to analyze hematopoiesis of theAGM region in vitro. Tissue of
the AGM region isolated from E11.5 embryos was dissociated into a single-cell
suspension and cultured in the presence of SCF, bFGF, LIF, and OSM for 10 days.
Then, ﬂoating hematopoietic cells spontaneously generated in the culture were
harvested and analyzed for expression of cell-surface markers and progenitor
activities. (B) AGM/FL coculture. The AGM/FL coculture system was designed to
analyze the interaction betweenAGM HSCs and the FL hematopoietic microenviron-
ment. Nonhematopoietic FLcells from E14.5 embryos were ﬁrst cultured for 2 days to
create a hematopoietic microenvironment, and thenAGM-derived cells (either whole
or CD341/c-Kit1 cells) were overlaid. Ten days later, ﬂoating hematopoietic cells
generated from input cells over the stromal layer were harvested and analyzed as in
(A). To distinguish donor cells from recipients, GFP1 embryos were used as input
cells in both systems.
Figure 2. Expansion of AGM-derived cells by coculture with FL cells. Floating
hematopoietic cells generated under various culture conditions were harvested after
10 days of incubation. GFP1 cells were counted by FACS. Under these culture
conditions, 40% to 80% of ﬂoating cells were GFP1. Results are shown as fold
expansion relative to the number of input cells. Note that FL cells provided a better
microenvironment for blood cell expansion than did AGM cells. Data shown are the
mean 6 SD of at least triplicate experiments.
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with the progression of embryonic development. The effect of
OSM was also different in the 2 sources of HSCs; OSM enhanced
the generation of hematopoietic cells from the AGM-derived
CD341/c-Kit1 cells, whereas it suppressed the production of
hematopoietic cells from the FL-derived CD341/c-Kit1 cells at
E14.5 and E18.5 in coculture with E14.5 FL cells. Dex in the
presence of OSM further reduced the production of hematopoietic
cells. These ﬁndings indicate that OSM has different effects on
hematopoiesis between AGM HSCs and FL HSCs in the same FL
microenvironment.
Because the ﬂoating hematopoietic cells were likely to be a
mixture of lineage-committed cells and immature cells, we exam-
ined hematopoietic progenitor activity of these cells by in vitro
colony-formation assays (Table 1). The colony-forming activity
was found only in CD341/c-Kit1 cells in AGM. Whereas the
frequency of colony-forming unit-culture (CFU-C) was not signiﬁ-
cantly different among the culture conditions, CFU-GEMM was
markedly expanded in the presence of OSM (Figure 4). In
conclusion, OSM enhanced the production of total hematopoietic
cells and immature hematopoietic progenitors from AGM HSCs.
Although the addition of Dex suppressed the production of total
hematopoietic cells, it enhanced the production of immature
progenitors from AGM HSCs in the FL microenvironment. Be-
cause OSM and Dex induce maturation of hepatic cells,22 matura-
tion of nonhematopoietic FL cells may provide a more suitable
microenvironment for expansion of immature progenitors, but not
for production of mature blood cells fromAGM HSCs.
Repopulating activity of HSCs generated in vitro
Because the most important characteristic of HSCs is the ability to
reconstitute the entire hematopoietic system in vivo, we trans-
planted the GFP1 hematopoietic cells generated in vitro into
lethally irradiated adult mice through the tail vein and analyzed the
donor contribution in the peripheral blood of recipient mice. We
compared the repopulating activity in the following 3 cell popula-
tions: total hematopoietic cells generated in the AGM culture
originating from 6 embryos, and the cells generated in theAGM/FL
coculture originating from either wholeAGM cells (1 3 105)o rt h e
CD341/c-Kit1 fraction of AGM cells (2 3 103), both of which
were equivalent to one third of the AGM cells from a single
embryo. Two months after transplantation, GFP1 cells in the
peripheral blood of recipients were analyzed by FACS (Figure 5A).
GFP1 cells were found in the myeloid (Mac-11,G r - 1 1 cells),
erythroid (Ter1191 cells), and lymphoid (B2201, Thy-11 cells)
compartments, as described previously.16 When the cells derived
from the AGM culture were transplanted, approximately 12% of
peripheral blood cells were found to be GFP1 (Figure 5A, lane a).
However, the cells from the AGM/FL coculture originating from
only one third of a single embryo were sufﬁcient to achieve a
comparable level of donor contribution (Figure 5A, lanes c, f),
suggesting that the number of in vivo repopulating cells was
increased during the AGM/FL coculture. As in immature progeni-
tors, the repopulation activity was dependent on the presence of
OSM during coculture, and the addition of Dex further elevated the
efﬁciency of repopulation (Figure 5A, lanes d, g). These ﬁndings
indicate that fetal hepatic cells provide a better hematopoietic
microenvironment than AGM for the maintenance and expansion
of the HSC activity ofAGM HSCs.
To analyze LTR-HSC activity in the cultured cells, we exam-
ined the donor contribution in peripheral blood for a longer period
after transplantation (Figure 5B).The donor contribution by freshly
isolated AGM cells in recipient mice was 15% at 1 month after
transplantation and reached 53% by 3 months after transplantation.
This level was maintained for at least 5 months. Flow cytometric
analysis of hematopoietic lineage markers in the recipient indicated
that donor cells were present in myeloid, lymphoid, and erythroid
compartments (data not shown). Consistent with previous stud-
ies,4,5 these results indicate that E11.5AGM contained LTR HSCs.
On the other hand, donor contribution of cultured AGM cells was
approximately 14% during the ﬁrst 4 months after transplantation
and thereafter declined to 2%, indicating that the majority of
hematopoietic progenitor cells generated in AGM culture were
short-term repopulating cells (STRCs)/committed progenitors and
thatAGM culture was unable to maintain LTR HSCs effectively. In
sharp contrast, when AGM cells were cultivated in the FL
Table 1. In vitro colony-formation assay
Cells
CFU-C
(/104 cells)
CFU-GEMM
(/104 cells)
CFU-C
(/dish)
CFU-GEMM
(/dish)
AGM CD341/c-Kit1 54 6 15 7 6 7 12.6 1.4
AGM (CD341/c-Kit1)2 0.15 6 0.14 0 — —
AGM CD341/c-Kit1/FL
coculture
SCF 50 6 12 0.4 6 0.5 1.1 3 104 92
SCF 1 OSM 75 6 30 1 6 2 2.6 3 104 330
SCF 1 OSM 1 Dex 40 6 52 6 0.8 0.7 3 104 360
GFP1 cells were sorted from coculture of GFP1AGM-derived CD341/c-Kit1 with
FL cells in the presence of cytokines, as indicated, at day 10. For comparison,
CD341/c-Kit1 cells and the remainder (CD341/c-Kit2, CD342/c-Kit1, and CD342/
c-Kit2 cells; AGM [CD341/c-Kit1]2) of primary E11.5 AGM cells were also applied to
colony-formation assays. The number and type of colonies were determined at day
14. The number of each type of colony was normalized to 1 3 104 cells applied to the
assay. InAGM/FLcoculture, 2 3 103 CD341/c-Kit1 cells were cocultured with FLcells
for 10 days, and resulted in 2.3 3 106, 3.3 3 106, and 1.8 3 106 cells with SCF, SCF 1
OSM, and SCF 1 OSM 1 Dex, respectively.
AGM indicates aorta-gonad-mesonephros; FL, fetal liver; SCF, stem cell factor;
OSM, oncostatin M; Dex, dexamethasone; CFU-GEMM, colony-forming unit-
granulocyte, erythrocyte, macrophage, and megakaryocyte.
Figure 4. Expansion of CFU-GEMM in the AGM/FL coculture. Immature hemato-
poietic progenitors in ﬂoating cells generated in vitro were examined by colony
assays. GFP1 cells were sorted from total hematopoietic cells generated and used
for an in vitro colony-formation assay. As a control, CD341/c-Kit1 cells in freshly
isolated E11.5AGM were similarly tested. Fold expansion relative to the control level
is shown in the ﬁgure. The number and type of colonies were determined at day 10.
Data shown are mean values of at least triplicate experiments.
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donor contribution (up to 70%) was readily achieved within 1
month and was maintained for at least 5 months. These results
indicate that AGM/FL cocultured cells contained a signiﬁcant
number of LTR HSCs and STRCs. It is generally accepted that LTR
HSCs contribute to hematopoiesis, but STRCs disappear at 5
months after transplantation.29,30The level of donor contribution by
AGM/FL cocultured cells was higher (82%) than that by freshly
isolated AGM cells (52%), even though the number of cells added
to the AGM/FL coculture was 9-fold less than that to the AGM
culture. It is therefore likely that the FL microenvironment
increases LTR HSCs derived from AGM in the presence of SCF
and OSM.
Engraftment of HSCs to the bone marrow
The donor contribution in the peripheral blood as shown above
strongly suggested that LTR HSCs are generated in AGM/FL
coculture from AGM HSCs, whereas AGM culture produces
mainly STRCs. Therefore, there is a clear difference in charac-
teristics of hematopoietic progenitor cells generated from AGM
HSCs between the AGM and FL microenvironments. Because
hematopoiesis from STRCs is not sustained longer than 4
months after transplantation,29,30 we analyzed the donor contri-
bution in various hematopoietic organs at 3 months after
transplantation (Figure 6A). The cells generated inAGM culture
were poorly engrafted in every organ tested. The efﬁciency of
engraftment of progenitor cells to hematopoietic organs relative
to peripheral blood cells revealed that engraftment to the bone
marrow was particularly low in comparison with other organs
(Figure 6B, left panel). The level of donor contribution in
peripheral blood was similar to that in spleen (Figure 6B, left
panel), suggesting that spleen is the dominant hematopoietic site
for cultured AGM cells. In contrast, the AGM/FL cocultured
cells contributed at high levels to all organs including the bone
marrow (Figure 6A), and there was no substantial difference in
the efﬁciency of engraftment to each organ (Figure 6B, right
panel). Taken together with the results of the long-term repopu-
lation analysis, the data suggest that cultivation ofAGM cells in
the AGM microenvironment generates mainly STRCs, which
reside in the spleen even 3 months after transplantation. In
contrast, AGM/FL coculture in the presence of OSM generates
both STRCs/committed progenitor cells and LTR HSCs from
AGM HSCs, which effectively colonize in spleen and
bone marrow.
Figure 6. Donor contribution in hematopoietic tissues. (A) Recipient mice were
killed at 3 months after transplantation, and the levels of the donor contribution in
hematopoietic tissues were determined by FACS. (B) Relative contribution of donor
cells in various hematopoietic tissues. To compare the contribution of donor cells
among various hematopoietic tissues in recipients, the levels of the donor contribu-
tion in various tissues relative to that in peripheral blood cells were calculated. The
cells fromAGM cultures were poorly colonized, particularly in the bone marrow.
Figure 5. In vivo repopulating activity of cells generated in vitro. (A) To analyze
HSC activity in vivo, hematopoietic cells generated in vitro under various culture
conditions were transplanted into lethally irradiated adult mice. Donor contribution in
peripheral blood of recipient mice was analyzed by FACS at 2 months after
transplantation. Donor cells used are as follows: (lane a) cells derived from AGM
culture originating from 6 embryo equivalents (see Figure 1); (lanes b-d) cells from
AGM/FL coculture originating from one-third embryo equivalent of whole AGM cells
(approximately 1 3 105 cells); and (lanes e-g) CD341/c-Kit1 cells (2 3 103) derived
from AGM (one-third embryo equivalent). Data shown are the mean 6 S Do f3t o5
experiments. (B) LTR activity of cells either freshly isolated from the E11.5 AGM
region or generated in vitro. Mice were killed at various times, and peripheral blood
cells were analyzed for donor contribution by FACS. Data are the mean 6 SD values
of 3 to 5 experiments.
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HSCs are the best characterized stem cell system and have been
used to study various concepts in stem cell biology.31 To clarify the
characteristics of HSCs and the microenvironment during embry-
onic development, we have developed a primary coculture system
composedofAGM-derivedhematopoieticcellsandnonhematopoi-
etic FL cells. This system is capable of supporting AGM HSCs to
generate a number of lineage-committed progenitors and LTR
HSCs. The cell population in AGM contributing to the production
of hematopoietic cells in the FL microenvironment was found
exclusively in CD341/c-Kit1 cells, consistent with the previous
ﬁndings that HSCs in both AGM and FL were detected only in the
CD341/c-Kit1 fraction.28 HSCs change their proliferation potential
during development, and AGM HSCs produced signiﬁcantly more
hematopoietic cells than FL HSCs in the FL microenvironment.
Furthermore, E18.5 FL HSCs produced fewer hematopoietic cells
than E14.5 FL HSCs in the coculture system (Figure 3, lanes h-m).
These ﬁndings strongly suggest that the proliferation potential of
HSCstoproducehematopoieticcellsdecreasesalongwithdevelop-
ment. Alteration of HSC characteristics is also suggested by their
response to OSM in the FL microenvironment: OSM enhanced the
generation of hematopoietic cells from the AGM-derived CD341/
c-Kit1 cells, whereas it suppressed hematopoiesis from the CD341/
c-Kit1 cells derived from FL at E14.5 and E18.5 in coculture with
E14.5 FLcells.
The most striking difference between the AGM culture and the
AGM/FL coculture was their ability to support expansion of
hematopoietic progenitors and LTR HSCs. Consistent with previ-
ous observations,5,28 we also found LTR-HSC activity in freshly
isolated E11.5 AGM cells (Figure 5B). The donor contribution in
peripheral blood in our system was relatively lower than those in
previous reports.5,28 In previous studies, donor cells with a genetic
marker were detected by polymerase chain reaction (PCR)–based
methods, whereas we used the GFPtransgenic mouse as a source of
donor cells and detected donor cells in the recipients by ﬂow
cytometry. Although PCR is very sensitive to detect donor cells,
ﬂow cytometry provides a more quantitative means to estimate
donor contribution. Thus, the difference between our results and
those of previous studies may be due to a difference in the detection
systems. Although the AGM culture increased the number of total
hematopoietic cells, cultured AGM cells exhibited mainly STRC/
committed progenitor activity. In sharp contrast, the AGM cells
grown in the FL microenvironment showed remarkable LTR-HSC
activity (Figure 5B). Whereas 6 embryos were required for LTR
using freshly isolated AGM cells, AGM/FL cocultured cells
originated from only two thirds of a single embryo were sufﬁcient
to reconstitute hematopoiesis with higher levels of donor contribu-
tion as early as 1 month after engraftment, and it lasted at least 5
months. These ﬁndings indicate that LTR HSCs and STRC/
committed progenitor cells are generated from AGM HSCs in
coculture and contribute to high levels of hematopoietic reconstitu-
tion immediately after transplantation.
The efﬁciency of the in vivo repopulating activity was highest
when coculture was performed in the presence of both OSM and
Dex, consistent with the generation of immature progenitors
(Figure 4). These ﬁndings apparently contradict the results shown
in Figures 2 and 3, as well as previous observations24 showing that
the number of total hematopoietic cells generated in the FL
microenvironment was reduced in the presence of both OSM and
Dex regardless of the source of hematopoietic cells. However, as
described previously,24 lineage-committed cells were more suscep-
tible to OSM and Dex in the FL microenvironment. Therefore, it is
conceivable that OSM and Dex affect the multilineage progenitor
(CFU GEMM) and/or lineage-committed cells. Our previous
ﬁndings showed that the combination of OSM and Dex causes
functional maturation of hepatic cells in primary FL culture to
express metabolic enzymes.22 By this combination, LTR-HSC
activity was strikingly expanded while the production of mature
blood cells was suppressed. In conclusion, these ﬁndings suggest
that our culture system is an excellent in vitro model of FL
development, in which expansion of LTR HSCs from AGM HSCs
and maturation of hepatic cells progress coordinately.
The cells from the AGM/FL coculture were efﬁciently repopu-
lated not only in the peripheral blood, but also in various
hematopoietic organs including the bone marrow at 3 months after
transplantation. In contrast, the cells from the AGM culture poorly
colonized in recipients, particularly in the bone marrow (Figure 6).
These ﬁndings are well correlated with the previous observation
that colonization to the bone marrow is a necessary step for
transplanted HSCs to maintain their LTR activity immediately after
transplantation.32 Consistent with this, the donor contribution in the
peripheral blood by the cells from AGM culture gradually de-
creased to a level similar to that in the bone marrow. It was shown
previously that the bone marrow homing activity of HSCs derived
from adult bone marrow declines by in vitro culture, despite a
signiﬁcantincreaseinthenumberofhematopoieticcells.33Because
the spleen contains abundant committed progenitors, our results
with transplantation of AGM cultured cells indicate that trans-
planted STRCs/committed progenitor cells also reside in spleen.
The AGM/FL coculture system allowed dramatic expansion of
multilineage progenitor cells as well as LTR HSCs with high
efﬁciency of engraftment to the bone marrow. These ﬁndings also
support that engraftment in bone marrow is necessary for mainte-
nance of LTR-HSC activity in the recipient. Because LTR-HSC
activity was ampliﬁed in vitro, this system will be useful for gene
transfer to LTR HSCs by retroviral vectors.Although the molecular
basis of how HSCs repopulate to hematopoietic organs is yet to be
investigated, it is possible that engraftment is mediated by soluble
as well as membrane-bound proteins such as chemokines and
integrins. Therefore, the FL microenvironment stimulated with
Figure 7.Apossible model for coordinated development of HSCs and liver. LTR
HSCs with CD341/c-Kit1 generated in AGM immediately migrate to the FL. Factors
including OSM that are secreted from hematopoietic cells induce maturation of
hepatic cells as a metabolic organ.The hepatic cells, in turn, stimulate expansion and
maturation of AGM HSCs to FL HSCs with reduced proliferation potential. The fetal
hepatic cells provide a hematopoietic microenvironment suitable for expansion of
AGM HSCs but not of FL HSCs. Accordingly, HSCs migrate from the liver to bone
marrow, the ﬁnal destination of HSCs.
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molecules in HSCs. Alternatively, it may selectively expand HSCs
expressing these molecules. The coculture system also recapitu-
lates these alterations of HSCs in vitro.
Taking these ﬁndings together with our previous observa-
tions,22-24 a model for development of the hematopoietic system
during embryonic life can be suggested (Figure 7). Deﬁnitive HSCs
ﬁrst arise in the AGM region from hemangioblasts. Because the
AGM microenvironment poorly supports hematopoiesis, HSCs
immediately colonize to the FL, where they proliferate as authentic
LTR HSCs and produce mature hematopoietic cells with the help of
the FLmicroenvironment. During this process, highly proliferative
AGM HSCs change their characteristics to FL HSCs, with less
proliferative potential. However, as reported previously,22 fetal
hepatic cells are also stimulated with factors such as OSM, which
are produced by hematopoietic cells, and undergo their own
developmental program to become a metabolic organ rather than a
hematopoietic microenvironment. Thus, the 2 different cellular
systems existing in the same organ coordinately regulate their
developmental processes. The present in vitro system provides a
novel means to dissect such complex processes at the cellular and
molecular levels.
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